3-Amino Cyclohexanone Derivatives for Liver Cancer Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for liver cancer, such as hepatocellular carcinoma, lack effective agents that can significantly inhibit cancer cell growth, and existing compounds often have limited efficacy.
Innovation Solution
Development of novel anticancer agents, specifically 3-amino derivatives of 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyldodeca-2,6,10-trienyl)cyclohex-2-enone compounds, which exhibit superior inhibition against liver cancer cells compared to their 3-hydroxyl analogs, with some showing 10 to 20-fold better performance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing anticancer agents are used for liver cancer treatment, then treatment can be provided, but efficacy is limited and cancer cell growth inhibition is insufficient
Solution Approach 1:
The patent applies parameter changes by systematically modifying the chemical structure of cyclohexanone derivatives, specifically changing substituents at positions 2, 3, and 4 of the cyclohexanone ring (including R1, R2, R3, R4, R5, R6 groups). These structural parameter changes result in compounds with significantly enhanced anticancer activity against liver cancer cells, achieving 10-20 fold improvement in efficacy compared to existing agents.
2Reliability
If novel 3-amino derivative compounds are developed, then inhibition of liver cancer cells is substantially improved, but compound development complexity increases
Solution Approach 1:
The patent applies local quality by introducing specific functional groups at particular positions of the cyclohexanone structure. The 3-amino derivative configuration with specific substituents (R1, R2, R3, R4, R5, R6) at defined positions creates localized regions of enhanced biological activity, achieving superior cancer cell inhibition without requiring complete structural redesign of the entire molecule.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Provided herein are compositions and methods of treating liver cancer by novel anticancer agents.